Literature DB >> 1503830

Insights into HIV chemotherapy.

R F Schinazi1, J R Mead, P M Feorino.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1503830     DOI： 10.1089/aid.1992.8.963

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  18 in total

Review 1.  Structural modifications of nucleosides in ionic liquids.

Authors:  Vineet Kumar; Virinder S Parmar; Sanjay V Malhotra
Journal:  Biochimie       Date:  2010-02-21       Impact factor: 4.079

2.  Antiviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase occur in specific RNA structural regions.

Authors:  R F Schinazi; R M Lloyd; C S Ramanathan; E W Taylor
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

Review 3.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

4.  Deoxycytidine production by metabolically engineered Corynebacterium ammoniagenes.

Authors:  Yun-Bom Lee; Hong Baek; Sang-Kyum Kim; Hyung-Hwan Hyun
Journal:  J Microbiol       Date:  2011-03-03       Impact factor: 3.422

5.  Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro.

Authors:  A R Bender; H von Briesen; J Kreuter; I B Duncan; H Rübsamen-Waigmann
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

6.  Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides.

Authors:  R F Schinazi; R M Lloyd; M H Nguyen; D L Cannon; A McMillan; N Ilksoy; C K Chu; D C Liotta; H Z Bazmi; J W Mellors
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

Review 7.  Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).

Authors:  E Sandström; B Oberg
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

8.  S-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1.

Authors:  T Fujiwara; A Sato; M el-Farrash; S Miki; K Abe; Y Isaka; M Kodama; Y Wu; L B Chen; H Harada; H Sugimoto; M Hatanaka; Y Hinuma
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

9.  Pharmacokinetics of antiviral polyoxometalates in rats.

Authors:  L Ni; F D Boudinot; S G Boudinot; G W Henson; G E Bossard; S A Martellucci; P W Ash; S P Fricker; M C Darkes; B R Theobald
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

10.  Pharmacokinetics and metabolism of racemic 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rhesus monkeys.

Authors:  R F Schinazi; F D Boudinot; S S Ibrahim; C Manning; H M McClure; D C Liotta
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.